Juliet Tammenoms Bakker, Director at RxSight, Inc. (RXST), bought 480,000 shares at $12.50 ($6.0M) on 2023-02-10, disclosed to the SEC on 2023-02-13.
Open-market purchase of $6.0M RXST by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| RXST | BUY | 2024-02-15 | $407K | — | Filing → |
| RXST | SELL | 2023-11-30 | $29.4M | — | Filing → |
| RXST | SELL | 2023-11-16 | $13.6M | — | Filing → |